β-thalassemia in Metropolitan France;Les β-thalassémies en France Métropolitaine

Presse Medicale

Volumn 32, Issue 22, 2003, Pages 1016-1021

  Badens, C ^a   North, M L ^b   Lena Russo, D ^a  

^a TIMONE HOSPITAL   (France)

^b ETABLISSEMENT FRANÇAIS DU SANG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CONTROLLED STUDY; EPIDEMIOLOGICAL DATA; FOLLOW UP; FRANCE; HEALTH SURVEY; HUMAN; IRON CHELATION; MAJOR CLINICAL STUDY; PREVALENCE;

ADOLESCENT; ADULT; AGED; BETA-THALASSEMIA; BLOOD COMPONENT TRANSFUSION; BONE MARROW TRANSPLANTATION; CHELATING AGENTS; CHILD; CHILD, PRESCHOOL; FEMALE; FRANCE; HEALTH STATUS; HEALTH SURVEYS; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; URBAN POPULATION;

EID: 0037716416     PISSN: 07554982     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Caussade L, Neimann N, Willig P. Un cas d'anémie du premier âge du type Cooley. Arch Fr Pédiatrie 1948; 5: 410-13.
2. Giraud P, Orsini A, Roussel J. À propos de trois observations de maladies de Cooley. Pédiatrie 1950; 5: 249.
3. Lena-Russo D, North ML, Girot R. Épidemiologie des maladies génétiques de l'hémoglobine en France métropolitaine. Revue du praticien 1992; 42: 1867-72.
4. Aguilar-Martinez P, Schved JP, Badens C et al. Iron overload in thalassaemias and genetic haemochromatosis. Eur J Haematol 2000; 64: 279-80.
5. Modell B, Khan M, Darlison M. Survival in B-thalassaemia major in the UK: data from the UK Thalassaemia Register. Lancet 2001; 355: 2051-2.
6. Olivieri N, Brittenham G, Iron-chelating therapy and the treatment of thalassemia. Blood 1997; 89: 739-61.
7. Lucarelli G, Andreani M, Angelucci E. The cure of the Thalassemia with bone marrow transplantation. Bone Marrow Transplantation 2001; suppl 1 1511-3.
8. Cario H, Stahnke K, Sander S, Kohne E. Epidemiological situation and treatment of patients with thalassemia major in Germany: results of the German multicenter β-thalassemia study. Ann Hematol 2000; 79: 7-12.
9. Borgna-Pignatti C, Rugolotto S, Stefano P et al. Survival and disease complications in Thalassemia Major. Ann NY Acad Sci 1998; 850: 227-31.
10. Prati D, Zanella A, Farma E et al. A multicenter prospective study on the risk of acquiring liver disease in antihepatitis C virus negative patients affected from homozygous β-thalassemia. Blood 1998; 92: 3460-4.
11. Kattamis A, Dinopoulos A, Ladis V, Berdousi H, Kattamis C. Variation of ferritin levels over a period of 15 years as a compliance chelation index in Thalassemic patients. Am Hematol 2001; 58: 221-4.
12. Cao A, Galanello R, Rosatelli MC, Argiolu F, De Virgiliis B. Clinical experience of managment of thalassemia: the Sardinian experience. Semin Hematol 1996; 33: 66-75.